4 not yet recruiting, 4 recruiting. 7 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Recruiting 4, Not yet recruiting 3 |
| Phase 2 | 6 | Not yet recruiting 4, Recruiting 2 |
Follow BL-M08D1: new trials by email Literature Review of BL-M08D1 trials Research Report on BL-M08D1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors BL-M08D1 - Melanoma, Solid Tumors | Phase 1 / Phase 2 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 30 | 2026-10-13 | 2026-10-29 |
| A Study of BL-M08D in Patients With Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors BL-M08D1 - Gastrointestinal Tumors, Solid Tumors | Phase 1 / Phase 2 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 60 | 2026-09-11 | 2026-10-13 |
| A Study of BL-M08D1 in Patients With Recurrent or Metastatic Gynecological Malignancies and Other Solid Tumors BL-M08D1 - Gynecological Tumors, Solid Tumors | Phase 1 / Phase 2 | Not yet recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 90 | 2026-09-01 | 2026-08-31 |
| A Study of BL-M08D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors BL-M08D1 - Head and Neck Squamous Cell Carcinomas, Solid Tumors | Phase 2 | Not yet recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 30 | 2026-09-01 | 2026-08-27 |
| A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma BL-M08D1, Rituximab, Gemcitabine Hydrochloride - Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | Not yet recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 204 | 2026-09-01 | 2026-09-14 |
| A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors BL-M08D1 - Nasopharyngeal Carcinoma (NPC), Solid Tumors | Phase 1 / Phase 2 | Not yet recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 30 | 2026-09-01 | 2026-09-14 |
| A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors BL-M08D1 - Solid Tumor | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 22 | 2025-02-12 | 2026-04-14 |
| A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies BL-M08D1 - Relapsed or Refractory Lymphoid Malignancies | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 22 | 2025-01-02 | 2026-01-21 |
Digestive System Neoplasms (1) · Lymphoma, Large B-Cell, Diffuse (1) · Melanoma (1) · Nasopharyngeal Carcinoma (1) · Recurrence (1) · Squamous Cell Carcinoma of Head and Neck (1)
Sichuan Baili Pharmaceutical Co., Ltd. (8)
China (8)